Vendor: Agilent Technologies, Inc., Santa Clara, CA
Amount: An estimated $111,003
Terms: One-time transaction
The University award process may be delayed up to thirty days as this award goes through a state approval process.
The hearing has been cancelled since no vendors registered to attend or submitted comments regarding this notice.
First published Friday, September 4, 2015
The University awarded a contract for Headspace Solvent Analyzer instrument to Agilent Technologies, Inc., Santa Clara, CA, for an estimated $111,003.
Purchase of Agilent's Headspace Solvent Analyzer instrument for testing analyses in the Forensic Toxicology Laboratory.
The laboratory has pending contracts with three medicinal cannabis cultivation centers in Illinois and the possibility of several more in the coming months/year. All require quality control and quality assurance testing as per state law. Additionally, the lab is expanding into human toxicological testing, which will include drug and alcohol analyses. Part of both cannabis and human toxicology testing is looking for residual solvents; this process can only be performed with Headspace instrumentation. The rest of the analyses will be performed on existing Agilent High Performance Liquid Chromatograph with tandem Mass Spectormeter (LCQQQ) and Gas Chromatography Mass Spectrometry (GC/MS) instruments at the lab.
The lab is moving into human toxicological testing, which will include extracting drugs and volatiles from whole blood, serum, and urine. The volatiles will include Ethanol (alcohol found in beer, wine, and liquor), Acetone (nail polish remover), Toluene (found in airplane glue), and Difluorethane (DFE). The drugs can range from Acetaminophen, Butalbital (a barbiturate used for migraines), 6-monoacetylmorphine (6-MAM â?? the main metabolite of heroin), Clonazepam (a benzodiazepine and the active ingredient in Klonipin), MDMA (ecstasy), and Phencyclidine (PCP).
The lab is additionally expanding into the analysis of medicinal plants, primarily cannabis, following requirements set up by the Illinois Department of Agriculture. The testing for medicinal cannabis involves analyses for Microbes, Mycotoxins, Residual Solvents, Potency, and Pesticide Residues. The microbial testing will include E. coli, Salmonella, Total Coliforms, Aspergillus spp, Mucor spp, and Penicillium spp. as well as for the mycotoxins possibly produced by these microbes. Residual solvent testing will look for solvents (butane, propane, hexane and others) used to extract the cannabinoids (the active components) from the plant material to be used in edible products; solvent levels in these edible products must be tested and shown to be below set miminum levels for sale and use. There are currently 272 pesticides approved for use on these plants; residue testing will assure that no others have been used and that the medicine is safe for consumption. Finally, the potency or precise levels of the cannabinoids in the plants will be tested.
Finally, the State of Illinois Department of Agriculture has also requested that the FTL expand the testing for medicinal cannabis to include Terpenes, aromatic compounds that are naturally occurring in many plants. Recent studies indicate that these may play a role in the medicinal effects displayed by cannabis. These compounds are also quite volatile (readily evaporate at a low temperature) and will be also be analyzed on the Headspace instrument.
The University has determined that this purchase is only economically available from this source because the item or service is copyrighted or patented and is not available except from the holder of the copyright or patent.
For additional information, contact:
State Purchasing Officer - Aaron M. Finder
We will hold a public hearing at the date, time and location specified below, if we
receive a request to testify regarding the sole source determination. We will also
hold a hearing if any vendor submits a signed statement showing the capability to
provide the stated supplies/services at or below the amount indicated.
The public hearing allows any interested party the opportunity to testify for or against
the sole source determination as described in this notice. The purpose of the hearing
is to receive information from the public in a reasonable manner. Formal rules of evidence
will not apply. The hearing officer will produce minutes of the hearing and may record
it in order to aid in the production of the minutes. After conclusion of the hearing we
will decide whether the sole source determination was appropriate.
We must receive any request to testify and any vendor statement no later than the
registration date and time indicated below. If we do not receive a timely request or statement, we will not hold
the hearing. We reserve the right to cancel the procurement prior to any scheduled hearing.
Please confirm the status of the hearing with the Hearing Contact.
September 23, 2015
401 S. Spring Street
If you cannot attend the meeting in-person at the primary location, you may attend via audio teleconference. Email or call the Hearing Contact for details.
James R. Thompson Center
100 West Randolph
Date, time, and location are
subject to change and/or cancellation. It is the responsibility of potential
participants to confirm these details prior to attendance.
September 18, 2015